The National Highways Authority of India (NHAI) is set to begin construction on a long-awaited interchange that will link the Yamuna Expressway with the Eastern Peripheral Expressway (EPE). The Uttar ...

Causes include reduced blood flow or peripheral neuropathy. Managing your blood sugar may help prevent it. Limb loss and amputation are a rare, but major complication of unmanaged diabetes.

Mysuru: The proposed Peripheral Ring Road (PRR) project by the Mysuru Urban Development Authority (MUDA) has gained further traction, with MUDA inviting global tenders for preparing a Detailed Project ...

Greater Noida: A major development has emerged regarding the connection between the Yamuna Expressway and the Eastern Peripheral Expressway in Greater Noida. It is being reported that an interchange ...

If the nerves in your legs and arms are affected, it’s called diabetic peripheral neuropathy. Diabetic neuropathy is usually caused by long-term high blood sugar levels (hyperglycemia), as well ...

Modulation of peripheral sensory inputs, including odorant perception, is involved in the control of mating and foraging behavior in addition to the central neuronal circuits. We therefore tested this ...

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...

Gurugram: The Southern Peripheral Road (SPR) has witnessed a remarkable transformation over the past five years, with property prices soaring by 125 per cent according to a report by PropEquity. Rates ...

Mysuru: Mysuru Urban Development Authority (Muda) is preparing to float a global tender this year, for the development of the Peripheral Ring Road (PRR). With Rs 7.75 crore allocated in this year ...

Overall survival (OS) at 1 year following mismatched unrelated donor (MMUD) peripheral blood stem cell transplantation in patients receiving myeloablative conditioning (MAC) and posttransplant ...

It plans to use proceeds from the Series C round to advance its lead program, ATSN-201, through clinical development and into a potential approval and launch as a treatment for X-linked retinoschisis ...